Cargando…

Stratification of COPD patients towards personalized medicine: reproduction and formation of clusters

BACKGROUND: The global initiative for chronic obstructive lung disease (GOLD) 2020 emphasizes that there is only a weak correlation between FEV(1), symptoms and impairment of the health status of patients with chronic obstructive pulmonary disease (COPD). Various studies aimed to identify COPD pheno...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Zelst, Cathelijne M., Goossens, Lucas M. A., Witte, Jan A., Braunstahl, Gert-Jan, Hendriks, Rudi W., Rutten-van Molken, Maureen P. M. H., Veen, Johannes C. C. M. in’t
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733189/ https://www.ncbi.nlm.nih.gov/pubmed/36494786 http://dx.doi.org/10.1186/s12931-022-02256-7

Ejemplares similares

The impact of the involvement of a healthcare professional on the usage of an eHealth platform: a retrospective observational COPD study
por: van Zelst, Cathelijne M., et al.
Publicado: (2021)

Implementing integrated care guidelines in asthma and COPD: It ain't easy!
por: Witte, Jan A., et al.
Publicado: (2023)

Analyses of abdominal adiposity and metabolic syndrome as risk factors for respiratory distress in COVID-19
por: van Zelst, Cathelijne M, et al.
Publicado: (2020)

Development of an integral assessment approach of health status in patients with obstructive airway diseases: the CORONA study
por: van den Akker, Edmée FMM, et al.
Publicado: (2015)

Adjusting for COPD severity in database research: developing and validating an algorithm
por: Goossens, Lucas MA, et al.
Publicado: (2011)

Effectiveness of the Assessment of Burden of COPD (ABC) tool on health-related quality of life in patients with COPD: a cluster randomised controlled trial in primary and hospital care
por: Slok, Annerika H M, et al.
Publicado: (2016)

Bacterial lysate add‐on therapy to reduce exacerbations in severe asthma: A double‐blind placebo‐controlled trial
por: de Boer, Geertje M., et al.
Publicado: (2021)

Antibiotic Prescriptions in Hospitalized Patients with an Exacerbation COPD and a Proven Influenza or RS Virus Infection
por: van Brummelen, Sigrid, et al.
Publicado: (2022)

ABC Index: quantifying experienced burden of COPD in a discrete choice experiment and predicting costs
por: Goossens, Lucas MA, et al.
Publicado: (2017)

Asthma exacerbation prevalence during the COVID-19 lockdown in a moderate-severe asthma cohort
por: de Boer, Geertje, et al.
Publicado: (2021)

Development of the Assessment of Burden of COPD tool: an integrated tool to measure the burden of COPD
por: Slok, Annerika H M, et al.
Publicado: (2014)

Association between lung function and exacerbation frequency in patients with COPD
por: Hoogendoorn, Martine, et al.
Publicado: (2010)

Cost-effectiveness of integrated COPD care: the RECODE cluster randomised trial
por: Boland, Melinde R S, et al.
Publicado: (2015)

The potential for integrated care programmes to improve quality of care as assessed by patients with COPD: early results from a real-world implementation study in The Netherlands
por: Cramm, Jane Murray, et al.
Publicado: (2012)

Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: a post-hoc analysis of the 4-year UPLIFT trial
por: Goossens, Lucas M A, et al.
Publicado: (2014)

Common challenges faced in EU-funded projects on integrated care for vulnerable persons
por: Rutten-van Mölken, Maureen
Publicado: (2017)

Asthma patients experience increased symptoms of anxiety, depression and fear during the COVID-19 pandemic
por: de Boer, Geertje M, et al.
Publicado: (2021)

STOP: an open label crossover trial to study ICS withdrawal in patients with a combination of obesity and low-inflammatory asthma and evaluate its effect on asthma control and quality of life
por: Witte, Jan A., et al.
Publicado: (2022)

The health economic impact of disease management programs for COPD: a systematic literature review and meta-analysis
por: Boland, Melinde RS, et al.
Publicado: (2013)

COVID-19 Contact Tracing Apps: Predicted Uptake in the Netherlands Based on a Discrete Choice Experiment
por: Jonker, Marcel, et al.
Publicado: (2020)

Value-based person-centred integrated care for frail elderly living at home: a quasi-experimental evaluation using multicriteria decision analysis
por: Hoedemakers, Maaike, et al.
Publicado: (2022)

Systemic impairment in relation to disease burden in patients with moderate COPD eligible for a lifestyle program. Findings from the INTERCOM trial
por: van Wetering, Carel R, et al.
Publicado: (2008)

How much does a heart valve implantation cost and what are the health care costs afterwards?
por: Huygens, Simone A, et al.
Publicado: (2018)

‘To use or not to use’: a qualitative study to evaluate experiences of healthcare providers and patients with the assessment of burden of COPD (ABC) tool
por: Slok, Annerika H M, et al.
Publicado: (2016)

Application of a theoretical model to evaluate COPD disease management
por: Lemmens, Karin MM, et al.
Publicado: (2010)

Cochrane corner: is integrated disease management for patients with COPD effective?
por: Kruis, Annemarije L, et al.
Publicado: (2014)

Projecting the COPD population and costs in England and Scotland: 2011 to 2030
por: McLean, Susannah, et al.
Publicado: (2016)

RECODE: Design and baseline results of a cluster randomized trial on cost-effectiveness of integrated COPD management in primary care
por: Kruis, Annemarije L, et al.
Publicado: (2013)

Exploring the Impact of Adding a Respiratory Dimension to the EQ-5D-5L
por: Hoogendoorn, Martine, et al.
Publicado: (2019)

Largely ignored: the impact of the threshold value for a QALY on the importance of a transferability factor
por: Vemer, Pepijn, et al.
Publicado: (2010)

How Can a Bundled Payment Model Incentivize the Transition from Single-Disease Management to Person-Centred and Integrated Care for Chronic Diseases in the Netherlands?
por: Bour, Sterre S., et al.
Publicado: (2023)

Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain
por: Rutten-van Mölken, Maureen P. M. H., et al.
Publicado: (2007)

The Fold-in, Fold-out Design for DCE Choice Tasks: Application to Burden of Disease
por: Goossens, Lucas M. A., et al.
Publicado: (2019)

Evaluating an integrated care pathway for frail elderly patients in Norway using multi-criteria decision analysis
por: Islam, M. Kamrul, et al.
Publicado: (2021)

Exploring the variation in implementation of a COPD disease management programme and its impact on health outcomes: a post hoc analysis of the RECODE cluster randomised trial
por: Boland, Melinde R S, et al.
Publicado: (2015)

Cost-effectiveness of the fixed-dose combination tiotropium/olodaterol versus tiotropium monotherapy or a fixed-dose combination of long-acting β2-agonist/inhaled corticosteroid for COPD in Finland, Sweden and the Netherlands: a model-based study
por: Hoogendoorn, Martine, et al.
Publicado: (2021)

How to Address Uncertainty in Health Economic Discrete-Event Simulation Models: An Illustration for Chronic Obstructive Pulmonary Disease
por: Corro Ramos, Isaac, et al.
Publicado: (2020)

The disease burden of multimorbidity and its interaction with educational level
por: Chen, Yi Hsuan, et al.
Publicado: (2020)

Systematic Review and Quality Appraisal of Cost-Effectiveness Analyses of Pharmacologic Maintenance Treatment for Chronic Obstructive Pulmonary Disease: Methodological Considerations and Recommendations
por: van der Schans, Simon, et al.
Publicado: (2016)

TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility
por: Büyükkaramikli, Nasuh C., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_uo4ni69rerht7eqipg132mmn2t